Up a level |
(2010) The safety and efficacy of biphasic insulin aspart 30 (BIAsp 30) in Iranians with type 2 diabetes: an open-label, non-randomised, multi-centre observational study - the Iran subgroup of the IMPROVE™ study. Endokrynologia Polska. pp. 364-370. ISSN 0423-104X